Publications

Effect of dietary counseling and dietary fiber on tolerability during weight management with EMP16 and conventional orlistat: a single-blind randomized pilot trial

Scientific Reports, 2026

Poster presented at CRS 2025 Annual Meeting and Exposition

Controlled Release Society Conference, 2025

The Supportive Effect of Acarbose to Orlistat in Weight Management — A Randomized, Double-Blind, Multiarm Phase 2 Trial

Obesity, 2025.

Poster presented at the European Conference on Obesity 2025

ECO, 2025.

Skärmbild av artikeln som beskrivs

A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled-Release Formulations Versus a Marketed Orlistat Product

Clinical Pharmacology in Drug Development, 2025

Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial

Obesity, 2022.

Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose

Clinical Pharmacology in Drug Development, 2021.

Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity

Obesity Science and Practice, 2019.